Cameron Kahn
YOU?
Author Swipe
View article: Euglycemic diabetic ketoacidosis caused by Empagliflozin complicated by failure to thrive in a geriatric patient
Euglycemic diabetic ketoacidosis caused by Empagliflozin complicated by failure to thrive in a geriatric patient Open
Euglycemic diabetic ketoacidosis (euDKA) is a rare but deadly complication of sodium-glucose cotransport-2 (SGLT-2) inhibitors. Primarily indicated for the treatment of Type 2 Diabetes Mellitus, the incidence of euDKA is expected to rise a…